产品特点
12028 EQUEST PRAM OX D90 SPC(c lean) MAY 2010
FE HLER! AUTOTE XT-EINTRAG NICHT DE FINIERT.
EQUEST PRAMOX ORAL GEL
SUMMARY OF PRODUCT CHARACTERISTICS
Equest Pramox 19.5 mg/g + 121.7 mg/g oral gel
Names used:
EQUEST PRAMOX ORAL GEL in all the countries except
Germany: EQUEST PRAMOX 19.5 mg/g + 121.7
mg/g Gel zum eingeben
Spain: EQUEST PRA-MOX
Portugal and Poland: EQUEST PRAMOX 19.5 mg/g + 121.7
mg/g oral gel
Denmark: Equest Pramox
Sweden: Cydectin Comp Vet.
Each g contains:
Active substances
Moxidectin
Praziquantel
19.5 mg
121.7 mg
Excipients
Benzyl alcohol (E1519)
Butylhydroxytoluene (E321)
For a full list of excipients, see section 6.1
220.0 mg
0.8 mg
Oral Gel.
Pale yellow to orange/pink oral gel.
4.1. Target species
Horses.
4.2. Indications for Use, specifying the target species
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
12028 EQUEST PRAM OX D90 SPC(c lean) MAY 2010
FE HLER! AUTOTE XT-EINTRAG NICHT DE FINIERT.
In horses :
For the treatment of mixed cestodes and nematodes or arthropods infections ,
caused by moxidectin and praziquantel sensitive strains of:
Large strongyles:
_Strongylus vulgaris_ (adult stages)
_Strongylus edentatus_ (adult stages)
_Triodontophorus brevicauda_ (adults)
_Triodontophorus serratus_ (adults)
_Triodontophorus_
_ _
_tenuicollis _ (adults)
Small strongyles (adults and intraluminal larval st
阅读完整的文件